Dipentum

Dipentum is a brand name of olsalazine, approved by the FDA in the following formulation(s):

DIPENTUM (olsalazine sodium - capsule; oral)

• 
  Manufacturer: MEDA PHARMS
  
  Approval date: July 31, 1990
  
  Strength(s): 250MG ^[RLD]

Has a generic version of Dipentum been approved?

No. There is currently no therapeutically equivalent version of Dipentum available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Dipentum. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Dipentum.

See also...

• Dipentum Consumer Information (Wolters Kluwer)
• Dipentum Consumer Information (Cerner Multum)
• Dipentum Advanced Consumer Information (Micromedex)
• Dipentum AHFS DI Monographs (ASHP)
• Olsalazine Consumer Information (Wolters Kluwer)
• Olsalazine Consumer Information (Cerner Multum)
• Olsalazine Advanced Consumer Information (Micromedex)
• Olsalazine Sodium AHFS DI Monographs (ASHP)